טוען...
The Future of Respiratory Syncytial Virus Disease Prevention and Treatment
Respiratory syncytial virus (RSV) is a major cause of respiratory tract infections in infants, young children, and older or immunocompromised adults. Although aerosolized ribavirin was licensed for RSV treatment on the basis of data demonstrating a reduced need for supplemental oxygen, ribavirin use...
שמור ב:
| הוצא לאור ב: | Infect Dis Ther |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Healthcare
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7926075/ https://ncbi.nlm.nih.gov/pubmed/33656652 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40121-020-00383-6 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|